Lexaria Bioscience Corp. (LEXX)
NCM – Real Time Price. Currency in USD
5.83
+0.04 (0.72%)
Market open: Aug 12, 2026, 10:04 AM EDT
5.79
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
5.83
+0.04 (0.72%)
Market open: Aug 12, 2026, 10:04 AM EDT
5.79
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $3.5M significantly exceed its total debt $86.7K, ensuring strong financial flexibility
Total current assets $4.1M exceed Total current liabilities $383.4K, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.60 | 6.05 | 10 | |
| Quick ratio | 10.60 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 255K | 226K | 464K | 706K | 194K |
| Gross Profit | 47K | 54K | 383K | 587K | 95K |
| Operating Income | -7M | -7M | -6M | -12M | -7M |
| Net Income | -7M | -7M | -6M | -12M | -8M |
| EBITDA | -6M | -6M | -6M | -12M | -7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | 57.14 | 5.5 |
| Next quarter | N/A | -314.29 | 1.0 |
| Current year | -97.14 | 59.09 | 5.5 |
| Next year | 6915 | -14.81 | 5.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -37.32 | -33.32 | 25.84 | 3.3 |
| Y/Y | -99.99 | 47.45 | 61.9 | 54.38 | 7.8 |
| 3y average | 48.62 | -27.99 | 9.86 | -37.99 | 4.5 |
| 5y average | 42.16 | -33.36 | 0.55 | -37.96 | 3.5 |
| Weighted average score | 4.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |